BIOMAT Database Logo BIOMAT Database Logo

Amniotic fluid alpha-fetoprotein is not a useful biological marker of pregnancy outcome. 1999

E Verspyck, and S Degré, and M F Hellot, and G Descargues, and C Philippe, and G Labadie, and J Bénichou, and J P Lemoine, and L Marpeau
Department of Obstetrics and Gynaecology, Rouen University Hospital, Rouen, France. verspyck@chu-rouen.fr

The aim of our study was to determine if the amniotic fluid alpha-fetoprotein (AFP) level could be a useful predictive biochemical marker of pregnancy outcome. Amniotic fluid AFP measurement was prospectively carried out over a three-year period. After excluding factors susceptible to modifying AFP measurements, 587 subjects with gestational age between 14 and 20 weeks were selected to compare the amniotic fluid AFP mean levels depending on the occurrence of an adverse outcome. No significant associations between amniotic fluid AFP level and poor pregnancy outcome, i.e. pre-eclampsia, preterm delivery, premature rupture of fetal membranes, fetal growth retardation and placental abnormalities were observed. The routine measurement of amniotic fluid alpha-fetoprotein during an amniocentesis procedure was not considered useful in predicting pregnancy complications.

UI MeSH Term Description Entries
D011237 Predictive Value of Tests In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test. Negative Predictive Value,Positive Predictive Value,Predictive Value Of Test,Predictive Values Of Tests,Negative Predictive Values,Positive Predictive Values,Predictive Value, Negative,Predictive Value, Positive
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011248 Pregnancy Complications Conditions or pathological processes associated with pregnancy. They can occur during or after pregnancy, and range from minor discomforts to serious diseases that require medical interventions. They include diseases in pregnant females, and pregnancies in females with diseases. Adverse Birth Outcomes,Complications, Pregnancy,Adverse Birth Outcome,Birth Outcome, Adverse,Complication, Pregnancy,Outcome, Adverse Birth,Pregnancy Complication
D011256 Pregnancy Outcome Results of conception and ensuing pregnancy, including LIVE BIRTH; STILLBIRTH; or SPONTANEOUS ABORTION. The outcome may follow natural or artificial insemination or any of the various ASSISTED REPRODUCTIVE TECHNIQUES, such as EMBRYO TRANSFER or FERTILIZATION IN VITRO. Outcome, Pregnancy,Outcomes, Pregnancy,Pregnancy Outcomes
D011262 Pregnancy Trimester, Second The middle third of a human PREGNANCY, from the beginning of the 15th through the 28th completed week (99 to 196 days) of gestation. Midtrimester,Pregnancy, Second Trimester,Trimester, Second,Midtrimesters,Pregnancies, Second Trimester,Pregnancy Trimesters, Second,Second Pregnancy Trimester,Second Pregnancy Trimesters,Second Trimester,Second Trimester Pregnancies,Second Trimester Pregnancy,Second Trimesters,Trimesters, Second
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000509 alpha-Fetoproteins The first alpha-globulins to appear in mammalian sera during FETAL DEVELOPMENT and the dominant serum proteins in early embryonic life. alpha-Fetoprotein,alpha Fetoprotein,alpha Fetoproteins

Related Publications

E Verspyck, and S Degré, and M F Hellot, and G Descargues, and C Philippe, and G Labadie, and J Bénichou, and J P Lemoine, and L Marpeau
Amniotic fluid alpha-fetoprotein levels and pregnancy outcome.
October 1987, American journal of obstetrics and gynecology,
E Verspyck, and S Degré, and M F Hellot, and G Descargues, and C Philippe, and G Labadie, and J Bénichou, and J P Lemoine, and L Marpeau
[Alpha-fetoprotein in the amniotic fluid in normal pregnancy].
January 1979, Annali di ostetricia, ginecologia, medicina perinatale,
E Verspyck, and S Degré, and M F Hellot, and G Descargues, and C Philippe, and G Labadie, and J Bénichou, and J P Lemoine, and L Marpeau
Raised amniotic fluid concentrations of alpha-fetoprotein in a twin pregnancy.
March 1977, British medical journal,
E Verspyck, and S Degré, and M F Hellot, and G Descargues, and C Philippe, and G Labadie, and J Bénichou, and J P Lemoine, and L Marpeau
Elevated maternal serum alpha-fetoprotein and amniotic fluid alpha-fetoprotein after multifetal pregnancy reduction.
December 1990, Obstetrics and gynecology,
E Verspyck, and S Degré, and M F Hellot, and G Descargues, and C Philippe, and G Labadie, and J Bénichou, and J P Lemoine, and L Marpeau
Interpreting amniotic-fluid alpha-fetoprotein.
January 1978, Lancet (London, England),
E Verspyck, and S Degré, and M F Hellot, and G Descargues, and C Philippe, and G Labadie, and J Bénichou, and J P Lemoine, and L Marpeau
Alpha-fetoprotein in amniotic fluid.
June 1973, Lancet (London, England),
E Verspyck, and S Degré, and M F Hellot, and G Descargues, and C Philippe, and G Labadie, and J Bénichou, and J P Lemoine, and L Marpeau
Clinical implications of amniotic fluid alpha-fetoprotein in twin pregnancy.
December 1989, The Journal of reproductive medicine,
E Verspyck, and S Degré, and M F Hellot, and G Descargues, and C Philippe, and G Labadie, and J Bénichou, and J P Lemoine, and L Marpeau
[Alpha-fetoprotein (AFP) in amniotic fluid].
September 1981, Sozial- und Praventivmedizin,
E Verspyck, and S Degré, and M F Hellot, and G Descargues, and C Philippe, and G Labadie, and J Bénichou, and J P Lemoine, and L Marpeau
Routine amniotic fluid alpha-fetoprotein assays.
April 1983, American journal of medical genetics,
E Verspyck, and S Degré, and M F Hellot, and G Descargues, and C Philippe, and G Labadie, and J Bénichou, and J P Lemoine, and L Marpeau
Amniotic fluid alpha-fetoprotein in anencephaly.
April 1974, Obstetrics and gynecology,
Copied contents to your clipboard!